Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases

Background:

• Developing effective vaccines against challenging pathogens like HIV requires strategies that induce robust T cell responses.
• High-avidity cytotoxic T lymphocytes (CTL) are crucial for recognizing and eliminating infected cells, but their generation can be difficult.

Purpose of the Study:

• To investigate whether prime-boost immunization with DNA vaccines and poxvirus vectors can generate high-avidity CTL populations.
• To assess the persistence and functional capacity of these vaccine-induced T cells.

Main Methods:

• Utilized tetrameric-MHC complexes and ex vivo lytic assays to quantify CTL frequencies and avidity.
• Employed a novel in vivo assay to measure the ability of CTL to eliminate antigen-expressing target cells.
• Administered prime-boost immunization using DNA vaccines and recombinant poxvirus vectors.

Main Results:

• Prime-boost immunization generated high frequencies of CTL recognizing low-antigen expressing target cells.
• These high-avidity CTL persisted for at least 6 months, comprising ~10% of CD8(+) T cells.
• Prime-boost immunized animals demonstrated enhanced elimination of target cells and rapid CTL expansion upon viral challenge (>30% of CD8(+) T cells).

Conclusions:

• Prime-boost immunization strategies are effective in generating persistent, high-avidity CTL populations.
• This approach holds promise for developing vaccines against difficult pathogens by enhancing early detection of infected cells.
• Optimizing T cell avidity represents a viable strategy for effective prophylaxis and immunotherapy.